UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | I | J | K | L | M | N | O | P | R | S | T | W
Number of items: 145.

A

Aleffi, S; Petrai, I; Bertolani, C; Parola, M; Colombatto, S; Novo, E; Vizzutti, F; ... Marra, F; + view all (2005) Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. HEPATOLOGY , 42 (6) pp. 1339-1348. 10.1002/hep.20965.

Anagnostopoulos, GK; Pereira, SP; Zaitoun, AM; Ragunath, K; Aithal, GP; (2005) "Sequential sampling" strategy optimises the use of two endoscopic ultrasound (EUS)-guided tissue sampling techniques. In: (Proceedings) Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week. (pp. AB269-AB269). MOSBY, INC

Ayaru, L; Bown, SG; Pereira, SP; (2005) Photodynamic therapy for pancreatic and biliary tract carcinoma. Int J Gastrointest Cancer , 35 (1) pp. 1-13. 10.1385/IJGC:35:1:001.

B

Bogdanos, D-P; Baum, H; Okamoto, M; Montalto, P; Sharma, UC; Rigopoulou, EI; Vlachogiannakos, J; ... Vergani, D; + view all (2005) Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology , 42 (2) pp. 458-465. 10.1002/hep.20788.

Bogdanos, DP; Meda, F; Baum, H; Gunsar, E; Lopes, R; Longhi, MS; Ma, Y; ... Vergani, D; + view all (2005) A microbial mimic of the dominant T-cell autoepitope accounts for primary biliary cirrhosis-specific antibodies to a now mimicking microbial antigen. In: JOURNAL OF HEPATOLOGY. (pp. 236 - 237). ELSEVIER SCIENCE BV

Brun, P; Castagliuolo, I; Pinzani, M; Palu, G; Martines, D; (2005) Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY , 289 (3) G571-G578. 10.1152/ajpgi.00537.2004.

Burroughs, AK; Sabin, C; Cailliez, V; Karam, V; Adam, R; Rolles, K; (2005) Liver transplantation: Predictive models for 3 and 12 month survival based on the ELTR registry. In: JOURNAL OF HEPATOLOGY. (pp. 6 - 7). ELSEVIER SCIENCE BV

Burroughs, AK; Westaby, D; (2005) Liver,Biliary tract and pancreatic disease. Kumar,P.,Clarke.Eds. Clinical Medicine, 6th Edition. pp. 347-418.

C

Caplin, B; Sweny, P; Burroughs, A; Emery, V; Griffiths, P; (2005) Antiviral treatment after solid organ transplantation. LANCET , 366 (9488) 806 - 807.

Caplin, B; Sweny, P; Burroughs, A; Emery, V; Griffiths, P; (2005) Antiviral treatment after solid organ transplantation. Lancet , 366 (9488) pp. 806-807. 10.1016/S0140-6736(05)67210-8.

Chan, CW; Carpenter, JR; Rigamonti, C; Gunsar, F; Burroughs, AK; (2005) Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: A staged prognostic model. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , 40 (9) pp. 1081-1089. 10.1080/00365520510023215.

Chan, CW; Gunsar, F; Feudjo, M; Rigamonti, C; Vlachogiannakos, J; Carpenter, JR; Burroughs, AK; (2005) Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 21 (3) pp. 217-226. 10.1111/j.1365-2036.2005.02318.x.

Cheshire, LM; Jalan, R; (2005) The cost of variceal bleeding in cirrhosis - A comparison of a decision based economic model and patient data. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 349A-349A). WILEY-BLACKWELL

Cholongitas, E; Marelli, L; Kerry, A; Senzolo, M; Goodier, D; Nair, D; Thomas, M; ... Burroughs, AK; + view all (2005) Different methods of creatinine measurment significantly affect meld scores. In: HEPATOLOGY. (pp. 204A - 205A). JOHN WILEY & SONS INC

Cholongitas, E; Papatheodoridis, GV; Vangeli, M; Terreni, N; Patch, D; Burroughs, AK; (2005) Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther , 22 (11-12) pp. 1079-1089. 10.1111/j.1365-2036.2005.02691.x.

Cholongitas, E; Senzolo, M; Triantos, C; Samonakis, D; Patch, D; Burroughs, AK; (2005) MELD is not enough--enough of MELD? J Hepatol , 42 (4) pp. 475-477. 10.1016/j.jhep.2005.02.002.

Cholongitas, E; Senzolo, M; Triantos, C; Samonakis, D; Patch, D; Burroughs, AK; (2005) MELD is not enough—enough of MELD? UNSPECIFIED

Chung, A; Emmanuel, A; (2005) Autonomic dysfunction after spinal cord injury. In: Weaver, LC and Polosa, C, (eds.) Autonomic dysfunction after spinal cord injury. Elsevier Science

Coward, SM; Selden, C; Mantalaris, A; Hodgson, HJF; (2005) Proliferation rates of HepG2 cells encapsulated in alginate are increased in a microgravity environment compared with static cultures. ARTIF ORGANS , 29 (2) 152 - 158.

D

D'Souza, R; Main, J; Crossey, M; Rosenberg, W; Murray-Lyon, IM; Hayward, C; Foster, GR; (2005) Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy - patients' views of early cessation of therapy. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 21 (1) pp. 43-47. 10.1111/j.1365-2036.2004.02295.x.

Damelin, LH; Kirwan, M; Coward, S; Collins, P; Cox, J; Selden, C; Hodgson, H; (2005) Fat-loaded insulin-resistant HepG2 cells are resistant to cytokine and pro-oxidant induced damage, but become damage-susceptible after down-regulation of AMP-activated kinase. In: HEPATOLOGY. (pp. 628A - 629A). JOHN WILEY & SONS INC

Davies, NA; Brealey, DA; Stidwill, R; Singer, M; Svistunenko, DA; Cooper, CE; (2005) Nitrosyl heme production compared in endotoxemic and hemorrhagic shock. FREE RADICAL BIO MED , 38 (1) 41 - 49. 10.1016/j.freeradbiomed.2004.09.026.

Davies, NA; Schnurr, K; Sen, S; Hodges, SJ; Matthes, G; Jalan, R; (2005) Serum albumin shows conformational, structural and functional abnormalities in cirrhotic patients, which worsen with severity of liver disease and are unaffected by albumin dialysis. In: HEPATOLOGY. (pp. 222A - 222A). JOHN WILEY & SONS INC

Denton, CP; Khan, K; Leoni, P; Xu, SW; Abraham, DJ; Black, CM; (2005) Conditional fibroblast-specific deletion of type 2 transforming growth factor beta receptor replicates digital contractures of late-stage scleroderma. In: ARTHRITIS AND RHEUMATISM. (pp. S173 - S173). WILEY-LISS

Denton, CP; Lindahl, GE; Khan, K; Xu, SW; Ong, VH; Gaspar, NJ; Lazaridis, K; ... Black, CM; + view all (2005) Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II transforming growth factor-beta receptor (T beta RII Delta k). J BIOL CHEM , 280 (16) 16053 - 16065. 10.1074/jbc.M413134200. Gold open access

Duarte, RF; Delgado, J; Shaw, BE; Wrench D J, E; M, P; D, D; A P, M; ... A, F; + view all (2005) Histologic features of the liver biopsy predict the clinical outcome for patients with graft-verus-host disease of the liver. Biology of Blood and Marrow Transplantation , 11 pp. 805-813.

E

Ebrahimkhani, M; Kiani, S; Payabvash, S; Dehpour, AR; Moore, KP; Mani, AR; (2005) Opioid-dependent modulation of autonomic function and S-nitrosylation of proteins in rats with cholestasis. In: (Proceedings) 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver. (pp. p. 70). ELSEVIER SCIENCE BV

Ebrahimkhani, MR; Mani, AR; Moore, K; (2005) Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis. GUT , 54 (12) pp. 1668-1671. 10.1136/gut.2004.056556. Green open access
file

Emmanuel, A; (2005) Frontiers in colorectal surgery. In: Phillips, RKS and Clark, S, (eds.) Frontiers in colorectal surgery. Tfm Pub Ltd

G

Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Grace, ND; Burroughs, AK; Planas, R; Escorsell, A; ... Portal Hypertension Collaborative Group, ; + view all (2005) Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med , 353 (21) pp. 2254-2261. 10.1056/NEJMoa044456. Green open access
file

Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Grace, ND; GBurroughs, AK; Planas, R; Escorsell, A; ... Makuch, R; + view all (2005) Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patient with cirrhosis. New England Journal of Medicine , 353 pp. 2254-2261.

H

Habib, MM; Selden, C; Hodgson, HFJ; Davidson, BR; (2005) Effect of ischaemia reperfusion injury and its modulation by glycine on regeneration of the ischaemic liver remnant. JOURNAL OF HEPATOLOGY , 42 51 - 52.

Habib, MM; Selden, C; Hodgson, HFJ; Davidson, BR; (2005) Ischaemic preconditioning impairs early regenerative response in the hepatic remnant. JOURNAL OF HEPATOLOGY , 42 51 - 51.

Habib, MM; Selden, C; Hodgson, HFJ; Davidson, BR; (2005) Regeneration of the ischaemic liver remnant and effect of glycine. In: GUT. (pp. A45 - A45). B M J PUBLISHING GROUP

Habib, MM; Selden, C; Hodgson, HFJ; Davidson, BR; (2005) Transient ischaemia and reperfusion impairs early regenerative response in the hepatic remnant. In: GUT. (pp. A45 - A45). B M J PUBLISHING GROUP

Hart, AL; Al-Hassi, HO; Rigby, RJ; Bell, SJ; Emmanuel, AV; Knight, SC; Kamm, MA; (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology , 129 (1) pp. 150-165.

I

Ippolito, S; Mani, AR; Moore, KP; (2005) A novel approach to measure reactive nitrogen species formation in cirrhosis. In: (Proceedings) 16th European Congress of Clinical Chemistry and Laboratory Medicine (EUROMEDLAB 2005). (pp. S158-S158). ELSEVIER SCIENCE BV

Ippolito, S; Mani, AR; Ollosson, RC; Moore, KP; (2005) Reactive nitrogen species and the pathogenesis of cirrhotic cardiomyopathy. In: (Proceedings) 57th Annual Meeting of the American-Association-for-Clinical-Chemistry. (pp. A97-A97). AMER ASSOC CLINICAL CHEMISTRY

J

Jalan, R; (2005) Acute liver failure: current management and future prospects. JOURNAL OF HEPATOLOGY , 42 S115-S123. 10.1016/j.jhep.2004.11.010.

Jalan, R; (2005) Acute liver failure: current management and future prospects. J Hepatol , 42 (Suppl(1)) S115-23.

Jalan, R; (2005) Gc-globulin to predict outcome in acute liver failure: A panacea? LIVER TRANSPLANT , 11 (10) 1169 - 1171. 10.1002/lt.20507.

Jalan, R; (2005) Hypothermia may impair hepatic regeneration in acute liver failure - Reply. GASTROENTEROLOGY , 128 (4) pp. 1144-1145. 10.1053/j.gastro.2005.02.049.

Jalan, R; (2005) Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. NEUROCHEM INT , 47 (1-2) 78 - 83. 10.1016/j.neuint.2005.04.010.

Jalan, R; Rose, C; (2005) Liver failure and intracerebral hypertension. In: Tisherman, S and Sterz, F, (eds.) Therapeutic Hypothermia. (pp. 179-191).

Jalan, R; Sen, S; Steiner, C; (2005) The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin-bound toxins - Reply. LIVER TRANSPLANTATION , 11 (7) p. 855. 10.1002/lt.20475.

Jalan, R; Shawcross, D; (2005) Treatment of hepatic encephalopathy - Reply. LANCET , 365 (9468) pp. 1385-1386. 10.1016/S0140-6736(05)66368-4.

K

Karageorgiou, H; Mookerjee, RP; Patani, NR; Pachiadakis, I; Usiskin, SI; Gillams, A; Lees, WR; ... Jalan, R; + view all (2005) 'Nipped in the Budd': hepatic venous outflow obstruction in evolution. EUR J GASTROEN HEPAT , 17 (1) 65 - 68.

Kennedy, P; Gehring, A; Burroughs, A; Senzolo, M; Selden, C; Rees, M; Dusheiko, G; (2005) Role of NKG2D signalling in the activation of intrahepatic T cells. In: HEPATOLOGY. (pp. 724A - 724A). JOHN WILEY & SONS INC

Klocke, R; Mani, AR; Moore, KP; Morris, CJ; Blake, DR; Mapp, PI; (2005) Inactivation of xanthine oxidoreductase is associated with increased joint swelling and nitrotyrosine formation in acute antigen-induced arthritis. CLIN EXP RHEUMATOL , 23 (3) 345 - 350.

Kostoula, V; Khan, K; Savage, K; Stubbs, M; Quaglia, A; Dhillon, AP; Hochhauser, D; (2005) Expression of c-kit (CD117) in neuroendocrine tumours - A target for therapy? ONCOL REP , 13 (4) 643 - 647.

L

Laurson, J; Selden, C; Hodgson, HJF; (2005) Hepatocyte progenitors in man and in rodents - multiple pathways, multiple candidates. INT J EXP PATHOL , 86 (1) 1 - 18.

Leandro, G; Rolando, N; Gallus, G; Rolles, K; Burroughs, AK; (2005) Monitoring surgical and medical outcomes: the Bernoulli cumulative SUM chart. A novel application to assess clinical interventions. Postgrad Med J , 81 (960) pp. 647-652. 10.1136/pgmj.2004.030619.

M

Ma, Y; Meregalli, M; Hodges, S; Davies, N; Bogdanos, DP; Fargion, S; Fiorelli, G; (2005) Alcohol dehydrogenase: An autoantibody target in patients with alcoholic liver disease. International Journal of Immunopathology and Pharmacology , 18 (1) pp. 173-182. 10.1177/039463200501800118.

Ma, Y; Meregalli, M; Hodges, S; Davies, N; Bogdanos, DP; Fargion, S; Fiorelli, G; (2005) Alcohol dehydrogenase: An autoantibody target in patients with alcoholic liver disease. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY , 18 (1) pp. 173-182. 10.1177/039463200501800118.

Malik, R; Bungay, A; Riemann, M; Schmid, R; Brown, D; Hubank, M; Selden, C; (2005) Stimulation of hepatocyte proliferation and liver growth by triodothyronine (T3) and it's relationship to Bcl-3 expression. In: HEPATOLOGY. (pp. 301A - 302A). JOHN WILEY & SONS INC

Mani, A; Montagnese, S; Jackson, C; Moore, KP; Morgan, MY; (2005) Heart rate variability shows a significant positive correlation with neuropsychiatric status in patient with cirrhosis. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 410A-410A). JOHN WILEY & SONS INC

Mani, AR; Montagnese, S; Jackson, C; Moore, KP; Morgan, MY; (2005) Decreased heart rate variability correlates with neuropsychiatric impairment in cirrhotic patients. In: (pp. 410A, 544-).

Mani, AR; Moore, KP; (2005) Dynamic assessment of nitration reactions in vivo. METHOD ENZYMOL , 396 151 - 159. 10.1016/S0076-6879(05)96015-1.

Marra, F; DeFranco, R; Robino, G; Novo, E; Efsen, E; Pastacaldi, S; Zamara, E; ... Parola, M; + view all (2005) Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. WORLD JOURNAL OF GASTROENTEROLOGY , 11 (32) pp. 4931-4938. Gold open access

Mattes, FM; Hainsworth, EG; Hassan-Walker, AF; Burroughs, AK; Sweny, P; Griffiths, PD; Emery, VC; (2005) Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J INFECT DIS , 191 (1) 89 - 92.

Mazzocca, A; Coppari, R; De Franco, R; Cho, JY; Libermann, TA; Pinzani, M; Toker, A; (2005) Secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. CANCER RESEARCH , 65 (11) pp. 4728-4738. 10.1158/0008-5472.CAN-04-4449.

Mazzocca, A; Sciammetta, SC; Carloni, V; Cosmi, L; Annunziato, F; Harada, T; Abrignani, S; (2005) Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. JOURNAL OF BIOLOGICAL CHEMISTRY , 280 (12) pp. 11329-11339. 10.1074/jbc.M410161200. Gold open access

McStay, M; Savage, K; Stubbs, M; Khan, K; Dhillon, A; Caplin, M; (2005) Expression of parathyroid hormone related protein and the PTH/PTHrP receptor in human pancreatic adenocarcinoma. In: (Proceedings) Annual Meeting of the British-Society-of-Gastroenterology. (pp. A59-A59). B M J PUBLISHING GROUP

Montagnese, S; Gordon, HM; Jackson, C; Smith, J; Tognella, P; Jethwa, N; Sherratt, RM; (2005) Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment. Hepatology , 42 (4) pp. 772-781. 10.1002/hep.20855. Green open access
filefile

Montagnese, S; Jackson, C; Ennen, JC; Krause, J; Tillmann, HL; Morgan, MY; Weissenborn, K; (2005) Evidence of central nervous system (CNS) involvement in patients with chronic hepatitis C (HCV) infection and minimal liver disease. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 429A-429A). JOHN WILEY & SONS INC

Montagnese, S; Jackson, C; Ennen, JC; Tillman, HL; Morgan, MY; Weissenborn, K; (2005) Evidence of central nervous system involvement in patients with chronic hepatitis C viral infection and minimal liver disease. In: (pp. 429A, 592-).

Montagnese, S; Jackson, C; Morgan, MY; (2005) Classifying hepatic encephalopathy (HE): Does treatment status matter? In: (Proceedings) 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver. (pp. pp. 83-84). ELSEVIER SCIENCE BV

Montagnese, S; Jackson, C; Morgan, MY; (2005) Classifying hepatic encephalopathy (HE): does treatment status matter? In: (pp. 83, 214-).

Montagnese, S; Middleton, B; Mani, A; Skene, D; Morgan, MY; (2005) Plasma melatonin abnormalities in patients with cirrhosis reflect both hepatic and cerebral dysfunction. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 755A-755A). JOHN WILEY & SONS INC

Montagnese, S; Middleton, B; Mani, A; Skene, DJ; Morgan, MY; (2005) Plasma melatonin abnormalities in patients with cirrhosis reflect both hepatic and cerebral dysfunction. In: (pp. 755A, LB16-).

Mookerjee, R; Jalan, R; (2005) Alcoholic Liver Diseases. In: Weinstein, WM and Hawkey, CJ and Bosch, J, (eds.) Gastroenterology and Hepatology: The Modern Clinician’s Guide. (pp. 637-646).

Mookerjee, RP; Davies, NA; Sen, S; Hodges, SJ; Turner, C; Dalton, RN; Williams, R; (2005) Decreased hepatic extraction of asymmetric and symmetric dimethylarginine (ADMA/SDMA-NOS inhibitors) in acute alcoholic hepatitis may contribute to impaired end-organ function. In: HEPATOLOGY. (pp. 419A - 419A). JOHN WILEY & SONS INC

Mookerjee, RP; Jalan, R; (2005) Alcoholic Liver Disease. In: Weinstein, WM and Hawkey, CJ and Bosch, J, (eds.) Clinical Gastroenterology And Hepatology. (pp. 637-646). Elsevier Mosby

Mookerjee, RP; Sen, S; Davies, NA; Hodges, S; Turner, C; Dalton, RN; Williams, R; (2005) Dimethylarginine (nos inhibitor) levels predict in-patient mortality in alcoholic hepatitis. In: HEPATOLOGY. (pp. 493A - 493A). JOHN WILEY & SONS INC

Mookerjee, RP; Ytrebo, LM; Sen, S; Davies, NA; Hodges, S; Turner, C; Dalton, RN; ... Jalan, R; + view all (2005) Deranged dimethylarginine (NOS inhibitor) metabolism is associated with progressive organ injury in a devascularised pig model of acute liver failure. In: HEPATOLOGY. (pp. 357A - 357A). JOHN WILEY & SONS INC

Moore, K; Dusheiko, G; (2005) Opiate abuse and viral replication in hepatitis C. American Journal of Pathology , 167 pp. 1333-1340.

Moore, K; Dusheiko, G; (2005) Opiate abuse and viral replication in hepatitis C. AMERICAN JOURNAL OF PATHOLOGY , 167 (5) pp. 1189-1191. 10.1016/S0002-9440(10)61207-2.

Moore, K; Dusheiko, G; (2005) Opiate abuse and viral replication in hepatitis C. (Commentary). American Journal of Pathology , 167 (5) pp. 1189-1191.

Morgan, MY; (2005) Alcohol the nutrient. In:

Morgan, MY; (2005) Meta-analytical assessment of the efficacy of acamprosate in the treatment of alcohol dependence and the predictors of outcome. Drugs and Therapeutic Perspectives , 4 pp. 22-29.

Morgan, MY; Amodio, P; (2005) Treatment for hepatic encephalopathy: tips from TIPS? J HEPATOL , 42 (5) 626 - 628. 10.1016/j.jhep.2005.03.001.

Morgan, MY; Landron, F; Lehert, P; (2005) The severity of alcohol dependence does not influence the efficacy of treatment with acamprosate. In:

Murray, CDR; Martin, NM; Patterson, M; Taylor, SA; Ghatei, MA; Kamm, MA; Johnston, C; ... Emmanuel, AV; + view all (2005) Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. GUT , 54 (12) pp. 1693-1698. 10.1136/gut.2005.069088. Green open access
file

N

Nikolopoulos, A; Oben, J; Wittmann, J; Webster, G; Pereira, S; (2005) Chronic pancreatitis reduces bone mass and increases fracture risk. In: GASTROENTEROLOGY. (pp. A472 - A472). W B SAUNDERS CO

O

O'Donohue, JW; Pereira, SP; Ashdown, AC; Haigh, CG; Wilkinson, JR; Williams, R; (2005) A controlled trial of ondansetron in the pruritus of cholestasis. ALIMENT PHARM THER , 21 (8) 1041 - 1045. 10.1111/j.1365-2036.2005.02430.x.

Orie, NN; Vallance, P; Jones, DP; Moore, KP; (2005) S-nitroso-albumin carries a thiol-labile pool of nitric oxide, which causes venodilation in the rat. AM J PHYSIOL-HEART C , 289 (2) H916 - H923. 10.1152/ajpheart.01014.2004.

P

Park, G; Katelaris, P; Jones, DB; Ngu, M; Le Couteur, D; (2005) Caution before embracing serum markers of liver fibrosis in clinical practice. GASTROENTEROLOGY , 128 (4) pp. 1145-1146. 10.1053/j.gastro.2005.02.044.

Patch, C; Roderick, P; Rosenberg, W; (2005) Comparison of genotypic and phenotypic strategies for population screening in hemochromatosis: assessment of anxiety, depression, and perception of health. GENETICS IN MEDICINE , 7 (8) pp. 550-556. 10.1097/01.GIM.0000182466.87113.ce.

Patch, C; Roderick, P; Rosenberg, W; (2005) Factors affecting the uptake of screening: A randomised controlled non-inferiority trial comparing a genotypic and a phenotypic strategy for screening for haemochromatosis. JOURNAL OF HEPATOLOGY , 43 (1) pp. 149-155. 10.1016/j.jhep.2005.02.018.

Patch, C; Roderick, P; Rosenberg, W; (2005) Haemochromatosis: the need for an agreed case definition. JOURNAL OF HEPATOLOGY , 43 (5) p. 911. 10.1016/j.jhep.2005.09.001.

Pereira, SP; Ayaru, L; Hatfield, ARW; Rogowska, A; Bown, S; (2005) Photodynamic therapy (PDT) of malignant biliary strictures using mesotetrahydroxyphenylchlorin (mTHPC). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 351S - 351S). AMER SOC CLINICAL ONCOLOGY

Pereira, SP; Ragunath, K; Devlin, J; Meadows, HM; (2005) Preliminary results of a phase II trial to examine the safety and efficacy of porfimer sodium photodynamic therapy (PDT) in locally advanced biliary tract carcinoma (BTC). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 352S - 352S). AMER SOC CLINICAL ONCOLOGY

Pereira, SP; Rowbotham, D; Fitt, S; Shearer, MJ; Wendon, J; Williams, R; (2005) Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K-1) in severe acute liver disease. J HEPATOL , 42 (3) 365 - 370. 10.1016/j.jhep.2004.11.030. Green open access
file

Pinzani, M; Rombouts, K; Colagrande, S; (2005) Fibrosis in chronic liver diseases: diagnosis and management. JOURNAL OF HEPATOLOGY , 42 S22-S36. 10.1016/j.jhep.2004.12.008.

R

Rahman, TM; Diakanov, I; Selden, C; Hodgson, H; (2005) Co-transplantation of encapsulated HepG2 and rat Sertoli cells improves outcome in a thioacetamide induced rat model of acute hepatic failure. TRANSPL INT , 18 (8) 1001 - 1009. 10.1111/j.1432-2277.2005.00156.x.

Robinson, PJA; (2005) EBM and the diagnosis of hepatocellular carcinoma. Br J Radiol , 78 (928) pp. 370-371. 10.1259/bjr/75613849.

Rolles, K; Fusai, G; Rolando, N; Koti, R; Patch, D; Davidson, BR; Burroughs, AK; (2005) Endoscopic biliary stenting facilitates safe and early removal of T-tube in liver transplant patients. Minerva Chir , 60 (1) pp. 31-35.

Rose, C; Sen, S; Zwingmann, C; Davies, NA; Butterworth, R; Ytrebo, LM; Revhaug, A; (2005) The pathophysiological basis of brain swelling of grey vs white matter in acute liver failure are different: Lessons from a study using MARS. In: HEPATOLOGY. (pp. 207A - 207A). JOHN WILEY & SONS INC

Rosenberg, W; (2005) Biomarkers as a first-line estimate of injury in chronic liver diseases: Time for a moratorium on liver biopsy? Reply. GASTROENTEROLOGY , 128 (4) p. 1148. 10.1053/j.gastro.2005.02.062.

Rosenberg, W; (2005) Caution before embracing serum markers of liver fibrosis in clinical practice - Reply. GASTROENTEROLOGY , 128 (4) p. 1146. 10.1053/j.gastro.2005.02.045.

S

Saich, RC; Selden, C; Rees, M; Hodgson, H; (2005) Molecular adsorbents recirculating system therapy does not decrease the ability of liver failure plasma to induce apoptosis and cell death. In: GUT. (pp. A49 - A49). B M J PUBLISHING GROUP

Saick, RC; Selden, C; Rees, M; Hodgson, H; (2005) N-acetylcysteine protects primary human hepatocytes from Fas-ligand binding induced apoptosis. In: GUT. (pp. A49 - A49). B M J PUBLISHING GROUP

Samonakis, DN; Cholongitas, E; Triantos, CK; Griffiths, P; Dhillon, AP; Thalheimer, U; Patch, DW; (2005) Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantion for HCV cirrhosis. J HEPATOL , 43 (6) 1091 - 1093. 10.1016/j.jhep.2005.08.005.

Samonakis, DN; Cholongitas, E; Triantos, CK; Griffiths, P; Dhillon, AP; Thalheimer, U; Patch, DW; (2005) Sustained,spontaneous disapperance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis. Journal of Hepatology , 43 pp. 1091-1093.

Samonakis, DN; Quaglia, A; Joshi, NM; Tibballs, JM; Nagree, A; Triantos, CK; Davies, N; ... Caplin, ME; + view all (2005) Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease. Eur J Gastroenterol Hepatol , 17 (11) pp. 1229-1232.

Samonakis, DN; Triantos, CK; Thalheimer, U; Quaglia, A; Leandro, G; Teixeira, R; Papatheodoridis, GV; ... Burroughs, AK; + view all (2005) Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. LIVER TRANSPLANT , 11 (4) 386 - 395. 10.1002/lt.20344.

Schulze-Krebs, A; Preimel, D; Popov, Y; Bartenschlager, R; Lohmann, V; Pinzani, M; Schuppan, D; (2005) Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. GASTROENTEROLOGY , 129 (1) pp. 246-258. 10.1053/j.gastro.2005.03.089.

Selden, C; (2005) Bioartificial liver. In: Nedović, V and Willaert, R, (eds.) Applications of cell immobilisation biotechnology. Springer Verlag

Sen, S; Jalan, R; (2005) Ideal hepatocyte: Quest for the holy grail. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , 20 (1) pp. 1-4. 10.1111/j.1440-1746.2004.03738.x.

Sen, S; Jalan, R; (2005) Ideal hepatocyte: quest for the Holy Grail. J Gastroenterol Hepatol , 20 (1) pp. 1-4. 10.1111/j.1440-1746.2004.03738.x.

Sen, S; Mookerjee, RP; Cheshire, LM; Davies, NA; Williams, R; Jalan, R; (2005) Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J HEPATOL , 43 (1) 142 - 148. 10.1016/j.jhep.2005.01.032.

Sen, S; Williams, R; Jalan, R; (2005) Emerging indications for albumin dialysis. AM J GASTROENTEROL , 100 (2) 468 - 475.

Senzolo, M; Cholongitas, E; Patch, D; Burroughs, AK; (2005) TIPS for veno-occlusive disease: is the contraindication real? Hepatology , 42 (1) pp. 240-241. 10.1002/hep.20773.

Senzolo, M; Cholongitas, E; Patch, D; Burroughs, AK; (2005) TIPS for veno-occlusive disease: is the contraindication real? Hepatology , 42 (1) pp. 240-241. 10.1002/hep.20773.

Senzolo, M; Cholongitas, EC; Patch, D; Burroughs, AK; (2005) Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol , 2 (4) pp. 182-190. 10.1038/ncpgasthep0143.

Shawcross, D; Jalan, R; (2005) Dispelling myths in the treatment of hepatic encephalopathy. LANCET , 365 (9457) 431 - 433. Green open access
filefilefile

Shawcross, D; Jalan, R; (2005) The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. CELL MOL LIFE SCI , 62 (19-20) 2295 - 2304. 10.1007/s00018-005-5089-0.

Shawcross, DL; Damink, SWMO; Butterworth, RF; Jalan, R; (2005) Ammonia and hepatic encephalopathy: The more things change, the more they remain the same. METAB BRAIN DIS , 20 (3) 169 - 179. 10.1007/s11011-005-7205-0.

Shawcross, DL; Hodges, SJ; Davies, NA; (2005) Hyperammonemia impairs neutrophil function. In: HEPATOLOGY. (pp. 408A - 408A). JOHN WILEY & SONS INC

Shawcross, DL; Hodges, SJ; Davies, NA; Lidder, S; Jalan, R; (2005) Moderate hypothermia abolishes neutrophil oxidative burst induced by hyperammonemia but phagocytosis is unaffected. In: HEPATOLOGY. (pp. 355A - 355A). JOHN WILEY & SONS INC

Stigliano, R; Burroughs, AK; (2005) Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't. J Hepatol , 43 (4) pp. 563-568. 10.1016/j.jhep.2005.07.015.

Storr, T; Cameron, BR; Gossage, RA; Yee, H; Skerlj, RT; Darkes, MC; Fricker, SP; ... Zubieta, J; + view all (2005) Ru-III complexes of Edta and Dtpa polyaminocarboxylate analogues and their use as nitric oxide scavengers. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (13) pp. 2685-2697. 10.1002/ejic.200500018.

Stubbs, M; Khan, K; Wickremasinghe, RG; Ganeshaguru, K; Caplin, ME; (2005) CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines. Oncology Reports , 14 (4) pp. 1055-1058.

Stubbs, M; Khan, K; Wickremasinghe, RG; Ganeshaguru, K; Caplin, ME; (2005) CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines. ONCOL REP , 14 (4) 1055 - 1058.

Such, J; Muñoz, C; Zapater, P; Pérez-Mateo, M; (2005) Bacterial DNA induces a proinflammatory immune response in patients with decompensated cirrhosis. Gut , 54 (10) 1500-.

T

Ten Have, GA; Blokland, A; Jalan, R; Deutz, NE; (2005) Neuropsychological and behavioural characterisation of a fully-reversible acetaminophen-induced model of hepatic encephalopathy (HE) in mice. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 358A-359A). WILEY-BLACKWELL

Ten Have, GA; Jalan, R; Deutz, NE; (2005) Evidence for marked disturbance in whole body and brain glutamate (GLU) metabolism with no alteration of glutamine II (GLN) metabolism in an acetaminophen induced fulminant hepatic encephalopathy (HE) mouse model. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 364A-365A). WILEY-BLACKWELL

Ten Have, GAM; Van den Heuvel, MGW; Blokland, A; Jalan, R; Deutz, NEP; (2005) Characterization of hepatic encephalopathy (HE) in an acetaminophen (APAP) induced acute liver failure (ALF) mouse model. In: (Proceedings) Experimental Biology 2005 Meeting/35th International Congress of Physiological Sciences. (pp. A1048-A1048). FEDERATION AMER SOC EXP BIOL

Thalheimer, U; Leandro, G; Samonakis, DN; Triantos, CK; Patch, D; Burroughs, AK; (2005) Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. Dig Liver Dis , 37 (8) pp. 601-608. 10.1016/j.dld.2005.02.009.

Thalheimer, U; Triantos, C; Samonakis, D; Patch, D; Burroughs, AK; Riddell, A; Perry, D; (2005) Endogenous heparinoids in acute variceal bleeding. Gut , 54 (2) pp. 310-311. 10.1136/gut.2004.051474.

Thalheimer, U; Triantos, CK; Samonakis, DN; Patch, D; Burroughs, AK; (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut , 54 (4) pp. 556-563. 10.1136/gut.2004.048181.

Triantos, C; Samonakis, D; Stigliano, R; Thalheimer, U; Patch, D; Burroughs, A; (2005) Antiviral therapy for recurrent hepatitis C infection after liver transplantation. UNSPECIFIED

Triantos, C; Samonakis, D; Stigliano, R; Thalheimer, U; Patch, D; Burroughs, A; (2005) Liver transplantation and hepatitis C virus: systematic review of antiviral therapy. Transplantation , 79 pp. 146-147.

Triantos, C; Samonakis, D; Stigliano, R; Thalheimer, U; Patch, D; Burroughs, A; (2005) Liver transplantation and hepatitis C virus: systematic review of antiviral therapy. Transplantation , 79 (3) pp. 261-268. 10.1097/01.tp.0000149696.76204.38.

Triantos, C; Samonakis, D; Thalheimer, U; Patch, D; Burroughs, A; (2005) The relationship between liver function and portal pressure: what comes first, the chicken or the egg? J Hepatol , 42 (1) pp. 146-147. 10.1016/j.jhep.2004.07.023.

Triantos, C; Vlachogiannakos, J; Armonis, A; Saveriadis, A; Kougioumtzian, A; Leandro, G; Manolakopoulos, S; ... Avgerinos, A; + view all (2005) Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation. Aliment Pharmacol Ther , 21 (12) pp. 1435-1443. 10.1111/j.1365-2036.2005.02457.x.

Tripathi, D; Hayes, PC; Redhead, DN; Jalan, R; (2005) Transjugular Intrahepatic Portosystemic Stent-Shunt: Technical considerations and clinical utility in the management of variceal haemorrhage. In: Sanyal, A and Shah, V, (eds.) Portal Hypertension: Pathobiology, Evaluation and Treatment. (pp. 235-247).

Tsochatzis, E; Papatheodoridis, GV; (2005) The role of leptin and adiponectin in chronic liver diseases. Annals of Gastroenterology , 18 (4) pp. 377-385. Gold open access

Tsochatzis, E; Vassilopoulos, D; Deutsch, M; Filiotou, A; Tasidou, A; Archimandritis, AJ; (2005) Angioimmunoblastic T-cell lymphoma-associated arthritis case report and literature review. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , 11 (6) pp. 326-328. 10.1097/01.rhu.0000195105.20029.07.

W

Webster, GJ; Burroughs, AK; Riordan, SM; (2005) Portal vein thrombosis -- new insights into aetiology and management. Alimentary Pharmacology and Therapeutics , 21 pp. 1-9.

Webster, GJM; Burroughs, AK; Riordan, SM; (2005) Review article: portal vein thrombosis - new insights into aetiology and management. ALIMENT PHARM THER , 21 (1) 1 - 9. 10.1111/j.1365-2036.2004.02301.x.

Webster, GJM; Pereira, S; (2005) Diagnostic & Interventional ERCP. In: Gastroenterology and Hepatology: the Modern Clinician’s Guide. (pp. 905-914). Elsevier Science: London.

Webster, GJM; Wittmann, J; Seward, E; Pereira, SP; Hatfield, ARW; (2005) Autoimmune pancreatitis/cholangiopancreatopathy: Evidence of multisystem involvement. In: GUT. (pp. A14 - A14). B M J PUBLISHING GROUP

Wiesenthal, A; Mookerjee, RP; Schilling, K; Jalan, R; Muller-Ester, W; (2005) Differential expression of NOSTRIN splice variants alpha and beta in cirrhotic liver diseases. In: (Proceedings) 46th Spring Meeting of the Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und-Toxikologie. (pp. R37-R37). SPRINGER

Wittmann, J; Pereira, SP; Bown, SG; (2005) Photodynamic therapy using talaporfin sodium (LS11) photosensitisation in the pancreas and surrounding tissues in the Syrian golden hamster. In: GUT. (pp. A13 - A13). B M J PUBLISHING GROUP

This list was generated on Sun Aug 18 06:28:26 2019 BST.